---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-038648"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T05:53:22.922529+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Heart Test Laboratories (HSCS) gets Nasdaq bid price deficiency notice; has 180 days to cure

## Summary
- Nasdaq notified HSCS on Aug 2, 2023 that common stock bid price was below $1.00 for 30 consecutive business days.
- No immediate impact on listing; company has 180 calendar days to regain compliance (close at $1.00+ for 10 straight days).
- If not cured, HSCS may qualify for an extra 180-day period by meeting other initial listing standards and intending a reverse split.
- Failure to cure could lead to delisting; company is evaluating options to regain compliance.

## SEC filing metadata
- accession: 0000950170-23-038648
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023038648/0000950170-23-038648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023038648/hscs-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-038648
- JSON: https://secwatch.observer/filing/0000950170-23-038648.json
- Plain text: https://secwatch.observer/filing/0000950170-23-038648.txt

## Key facts
- Listing & Compliance Notices
  HeartSciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: August 2, 2023, Heart Test Laboratories, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, based on the closing bid price for the previous 30 consecutive business days, the listing of the Company’s shares of common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule”). The letter from Nasdaq has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market. In accor
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023038648/0000950170-23-038648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.